CAS RN: 851909-08-5
(S)-N-Fmoc-2-(3′-butenyl)glycine
Product Availability
Choose a grade to view its available package options.
1 package records1 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20260608 |
100mg / 250mg / 1g / 5g / 25g |
Confirm by inquiry |
Shanghai | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g, 5g, 10g, 25g
- Available purity: >97%
- Inventory rows with stock: 6
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 851909-08-5
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
-- |
2
In Stock
|
Beijing |
Inquiry |
| 0.25g |
-- |
2
In Stock
|
Hong Kong |
Inquiry |
| 1g |
-- |
2
In Stock
|
Shenzhen |
Inquiry |
| 5g |
-- |
2
In Stock
|
Shenzhen |
Inquiry |
| 10g |
-- |
2
In Stock
|
Shenzhen |
Inquiry |
| 25g |
-- |
2
In Stock
|
Shanghai |
Inquiry |
| 1g |
>97% |
0
Out of Stock
|
Shanghai |
Inquiry |
| 5g |
>97% |
0
Out of Stock
|
Beijing |
Inquiry |
851909-08-5 / (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)hex-5-enoic acid
Standard CAS: 851909-08-5
Multi CAS: Yes
Basic Information
CAS
851909-08-5
Multi CAS
Yes
Molecular Formula
C21H21NO4
Molecular Weight
351.400000
Exact Mass
351.147058
InChI
InChI=1S/C21H21NO4/c1-2-3-12-19(20(23)24)22-21(25)26-13-18-16-10-6-4-8-14(16)15-9-5-7-11-17(15)18/h2,4-11,18-19H,1,3,12-13H2,(H,22,25)(H,23,24)/t19-/m0/s1
InChIKey
CPJQXKHZCVDRSX-IBGZPJMESA-N
Computed Properties
Structural Parameters
Heavy atom count
26
Aromatic heavy atom count
12
Fraction Csp3
0.24
Rotatable bonds
7
H-bond acceptors
3
H-bond donors
2
Molar refractivity
99.06
TPSA
75.63
LogP / Solubility
WLOGP
3.94
MLOGP
3.49
XLogP3
4.2
Consensus LogP
3.88
Log S (ESOL)
-4.38
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.29
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-6.06
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.06
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
3